Mincai Qian

538 total citations
35 papers, 342 citations indexed

About

Mincai Qian is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mincai Qian has authored 35 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 11 papers in Psychiatry and Mental health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mincai Qian's work include Treatment of Major Depression (10 papers), Tryptophan and brain disorders (6 papers) and Schizophrenia research and treatment (5 papers). Mincai Qian is often cited by papers focused on Treatment of Major Depression (10 papers), Tryptophan and brain disorders (6 papers) and Schizophrenia research and treatment (5 papers). Mincai Qian collaborates with scholars based in China, Australia and Hong Kong. Mincai Qian's co-authors include Xinhua Shen, Zhongxia Shen, Jianhong Yang, Wei Chen, Lili Wei, Yonggui Yuan, Luoyi Xu, Yuedi Shen, Xia Li and Yingchun Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Affective Disorders.

In The Last Decade

Mincai Qian

34 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mincai Qian China 10 86 65 63 57 53 35 342
Tammy D. Kim South Korea 9 118 1.4× 66 1.0× 52 0.8× 37 0.6× 22 0.4× 11 318
Aisha S. Shariq Canada 5 83 1.0× 62 1.0× 36 0.6× 38 0.7× 58 1.1× 5 307
Patricia Handschuh Austria 11 79 0.9× 34 0.5× 38 0.6× 32 0.6× 33 0.6× 26 269
Xinhua Shen China 16 105 1.2× 98 1.5× 58 0.9× 58 1.0× 48 0.9× 46 528
Daomin Zhu China 12 126 1.5× 73 1.1× 28 0.4× 38 0.7× 25 0.5× 27 366
Naoya Yuuki Japan 5 65 0.8× 70 1.1× 47 0.7× 26 0.5× 58 1.1× 6 290
Zhongxia Shen China 9 84 1.0× 41 0.6× 50 0.8× 34 0.6× 18 0.3× 30 295
Ellen Ji United States 9 97 1.1× 58 0.9× 30 0.5× 24 0.4× 35 0.7× 16 290
Olya Mikova Germany 4 52 0.6× 61 0.9× 35 0.6× 25 0.4× 26 0.5× 4 260
Dominique Piber Germany 13 101 1.2× 57 0.9× 39 0.6× 39 0.7× 23 0.4× 26 448

Countries citing papers authored by Mincai Qian

Since Specialization
Citations

This map shows the geographic impact of Mincai Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mincai Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mincai Qian more than expected).

Fields of papers citing papers by Mincai Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mincai Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mincai Qian. The network helps show where Mincai Qian may publish in the future.

Co-authorship network of co-authors of Mincai Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Mincai Qian. A scholar is included among the top collaborators of Mincai Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mincai Qian. Mincai Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qi, Mincai Qian, Zhifen Liu, et al.. (2025). Safety and efficacy of different initial doses of lurasidone in the schizophrenia treatment: A multi-center, randomized, open-label study. World Journal of Psychiatry. 15(10). 110968–110968.
2.
3.
4.
Ge, Chenjie, Xuefeng Wang, Yun-Hong Wang, et al.. (2023). PKCε inhibition prevents ischemia‑induced dendritic spine impairment in cultured primary neurons. Experimental and Therapeutic Medicine. 25(4). 152–152. 2 indexed citations
5.
Yu, Fang, et al.. (2023). Psychological trauma, posttraumatic stress disorder and trauma-related depression: A mini-review. World Journal of Psychiatry. 13(6). 331–339. 18 indexed citations
6.
Yu, Fang, Feng Ming, Xudong Zhao, et al.. (2022). Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder. Frontiers in Psychiatry. 13. 803220–803220. 5 indexed citations
7.
Fang, Yu, et al.. (2022). Study on the Changes in Circadian Rhythm Before and After Treatment and the Influencing Factors in Patients with Depression. Neuropsychiatric Disease and Treatment. Volume 18. 2661–2669. 3 indexed citations
8.
Wei, Lili, Yingchun Zhang, Jintao Wang, et al.. (2022). Parietal-hippocampal rTMS improves cognitive function in Alzheimer's disease and increases dynamic functional connectivity of default mode network. Psychiatry Research. 315. 114721–114721. 41 indexed citations
9.
Jia, Yanli, Luoyi Xu, Yingchun Zhang, et al.. (2021). Precision Repetitive Transcranial Magnetic Stimulation Over the Left Parietal Cortex Improves Memory in Alzheimer’s Disease: A Randomized, Double-Blind, Sham-Controlled Study. Frontiers in Aging Neuroscience. 13. 693611–693611. 23 indexed citations
10.
Chen, Jing, et al.. (2019). Clinical effectiveness of cognitive behavioural therapy on alcohol-dependent patients: an observation with the WeChat platform. General Psychiatry. 32(5). e100087–e100087. 8 indexed citations
11.
12.
13.
He, Qianqian, et al.. (2018). Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder. Biochemical and Biophysical Research Communications. 504(1). 137–142. 6 indexed citations
14.
Wang, Shiliang, Mincai Qian, Hua Zhong, et al.. (2015). Comparison of the effectiveness of duloxetine in depressed patients with and without a family history of affective disorders in first-degree relatives.. PubMed. 27(4). 237–45. 4 indexed citations
15.
Qian, Mincai, et al.. (2015). Caspase-8 Mediates Amyloid-β-induced Apoptosis in Differentiated PC12 Cells. Journal of Molecular Neuroscience. 56(2). 491–499. 18 indexed citations
16.
Shen, Xinhua, Yanfeng Wu, Xiaoquan Wang, et al.. (2014). Association analysis of COMT/MTHFR polymorphisms and major depressive disorder in Chinese Han population. Journal of Affective Disorders. 161. 73–78. 30 indexed citations
17.
Qian, Mincai, et al.. (2011). The effect of reproductive hormone level on delayed menses induced by risperidone in schizophrenic patients. Chin J Psychiatry. 44(3). 151–154. 1 indexed citations
18.
Qian, Mincai, et al.. (2009). Effect of aripiprazole on the hyperprolactinmia induced by risperidone in male schizophrenia patients. Chin J Psychiatry. 42(4). 224–227. 4 indexed citations
19.
Mao, Peixian, Yi‐lang Tang, Feng Jiang, et al.. (2006). Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population. Depression and Anxiety. 25(1). 46–54. 31 indexed citations
20.
Yang, Yifeng, Zeping Xiao, Weixiong Chen, et al.. (2004). Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population. Neuroscience Letters. 369(2). 126–131. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tammy D. Kim Breakdown of academic impact, for papers by Aisha S. Shariq Breakdown of academic impact, for papers by Patricia Handschuh Breakdown of academic impact, for papers by Xinhua Shen Breakdown of academic impact, for papers by Daomin Zhu Breakdown of academic impact, for papers by Naoya Yuuki Breakdown of academic impact, for papers by Zhongxia Shen Breakdown of academic impact, for papers by Ellen Ji Breakdown of academic impact, for papers by Olya Mikova Breakdown of academic impact, for papers by Dominique Piber
Rankless by CCL
2026